Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Yanik

Showing results (91-100 of 128) with videos related to

Pageof 13
Sort By:
Blood Advances|June 24, 2025
Evaluation of in vivo CAR transgene levels in tisagenlecleucel-treated patients with relapsed/refractory B-ALL and DLBCLRakesh Awasthi, Stephan A Grupp, Edward R Waldron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2011
Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: a report from the Children's Oncology GroupJudith G Villablanca, Wendy B London, Arlene Naranjo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2017
Validation of Postinduction Curie Scores in High-Risk Neuroblastoma: A Children's Oncology Group and SIOPEN Group Report on SIOPEN/HR-NBL1Gregory A Yanik, Marguerite T Parisi, Arlene Naranjo, et al.
Blood|February 14, 2018
α<sub>1</sub>-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host diseaseJohn M Magenau, Steven C Goldstein, Dan Peltier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 3, 2015
131I-metaiodobenzylguanidine with intensive chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma. A new approaches to neuroblastoma therapy (NANT) phase II studyGregory A Yanik, Judith G Villablanca, John M Maris, et al.
Translational Oncology|April 23, 2022
Improved prediction of radiation pneumonitis by combining biological and radiobiological parameters using a data-driven Bayesian network analysisTonaye Hinton, David Karnak, Ming Tang, et al.
Transplantation and Cellular Therapy|February 8, 2025
Restrictive Ventilatory Defects Following Hematopoietic Stem Cell Transplant Are Associated With Increased MortalityMansour Alkhunaizi, Felipe Soto-Lanza, Cheuk Hong Leung, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 9, 2020
Multicenter evaluation of parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantationGuang-Shing Cheng, Katherine E Selwa, Charles Hatt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 24, 2017
Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trialsRuth Ladenstein, Bieke Lambert, Ulrike Pötschger, et al.
Blood Cancer Discovery|January 12, 2022
Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic LeukemiaMichael A Pulsipher, Xia Han, Shannon L Maude, et al.
Pageof 13

Showing results (91-100 of 128) with videos related to

Sort By:
Pageof 13
Blood Advances|June 24, 2025
Evaluation of in vivo CAR transgene levels in tisagenlecleucel-treated patients with relapsed/refractory B-ALL and DLBCLRakesh Awasthi, Stephan A Grupp, Edward R Waldron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2011
Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: a report from the Children's Oncology GroupJudith G Villablanca, Wendy B London, Arlene Naranjo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2017
Validation of Postinduction Curie Scores in High-Risk Neuroblastoma: A Children's Oncology Group and SIOPEN Group Report on SIOPEN/HR-NBL1Gregory A Yanik, Marguerite T Parisi, Arlene Naranjo, et al.
Blood|February 14, 2018
α<sub>1</sub>-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host diseaseJohn M Magenau, Steven C Goldstein, Dan Peltier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 3, 2015
131I-metaiodobenzylguanidine with intensive chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma. A new approaches to neuroblastoma therapy (NANT) phase II studyGregory A Yanik, Judith G Villablanca, John M Maris, et al.
Translational Oncology|April 23, 2022
Improved prediction of radiation pneumonitis by combining biological and radiobiological parameters using a data-driven Bayesian network analysisTonaye Hinton, David Karnak, Ming Tang, et al.
Transplantation and Cellular Therapy|February 8, 2025
Restrictive Ventilatory Defects Following Hematopoietic Stem Cell Transplant Are Associated With Increased MortalityMansour Alkhunaizi, Felipe Soto-Lanza, Cheuk Hong Leung, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 9, 2020
Multicenter evaluation of parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantationGuang-Shing Cheng, Katherine E Selwa, Charles Hatt, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 24, 2017
Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trialsRuth Ladenstein, Bieke Lambert, Ulrike Pötschger, et al.
Blood Cancer Discovery|January 12, 2022
Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic LeukemiaMichael A Pulsipher, Xia Han, Shannon L Maude, et al.
Pageof 13